US FDA issues 12 observations for Cipla's Goa manufacturing facility
Cipla Ltd announced that United States Food and Drug Administration (FDA) conducted a cGMP inspection at Goa manufacturing facility from September 16-27, 2019.
The inspection ended with 12 observations, none of which are related to data integrity, the company said.
The company said it will respond to the agency within the stipulated timeline.
Let’s apply Data-Driven Pricing to Your APIs
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions!
Learn More!